Multi-center, parallel-group, open-label, randomized, comparative study in patients with tachyarrhythmia in sepsis versus those untreated (J-Land 3S study)

Trial Profile

Multi-center, parallel-group, open-label, randomized, comparative study in patients with tachyarrhythmia in sepsis versus those untreated (J-Land 3S study)

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 15 Nov 2017

At a glance

  • Drugs Landiolol (Primary)
  • Indications Tachycardia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms J-Land 3S study
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 15 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top